This outsourcing of labor is possible thanks to the emergence and widespread proliferation of automated DNA sequencing instruments, which can accomplish in one day what would take a whole team of re-searchers weeks to do. Because of their cost, these machines are typically found not in individual labs, but in centralized core facilities. Fredrik Vannberg, facility manager at the Dana Farber/Harvard Cancer Center high-throughput DNA se-quencing facility, says that his center typically runs 1,000 samples a day (five 96-well plates each on two machines), each typically producing about 600 "good quality bases." The facility processed nearly 75,000 samples in 2001, according to Vannberg.
The recent advances in automated DNA sequencing are only the most recent chapter in a story that spans almost three decades.1 Though the core technology hasn't changed since 1977—all of the automated DNA sequencers on the market today still follow Fred Sanger's basic 2',3'-dideoxynucleoside 5'-triphosphate ("dideoxy") protocol2—researchers ...
